Recruiting studies: Ureteral Stent Related Symptoms

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ComfiJ Versus Conventional Double-J Stent for Ureteral Stent Symptoms
NA · 3 location(s) · Beni-Suef University · NCT07627828 Dexamethasone for Ureteral STent Symptoms (DUSTS)
Phase 1/Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT06930690 Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms
Phase 3 · 1 location(s) · Bir Hospital · NCT06803030 Safety and Efficacy of Combination of Tamsulosin 0.4 mg Plus Tadalafil 5mg Versus 2.5 mg
NA · 1 location(s) · Ain Shams University · NCT07562282 Melatonin and Solifenacin for Double-J Ureteral Stent Symptoms
Phase 2 · 1 location(s) · Beni-Suef University · NCT07617922 Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms
Phase 3 · 2 location(s) · Penang Hospital, Malaysia · NCT06966804

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.